Skip to main content
Premium Trial:

Request an Annual Quote

TcLand to Use Genedata Software

NEW YORK (GenomeWeb News) – Biomarker developer TcLand Expression will use Genedata's Phylosopher and Expressionist software platforms in its research programs, Genedata said today.

Under the agreement, TcLand Expressions will integrate the two platforms into its computational infrastructure to support interdisciplinary biomarker identification, validation, and mode-of-action studies that are focused on transplantation and autoimmune disease research. Genedata said that the platforms will enable Nantes, France-based TcLand to "take a cross-technology approach by using automated workflows and integrated analysis tools to streamline the research workflow, from experimental design through to final results."

The Genedata Phylosopher software is used for target discovery and integrative data management, and Expressionist is designed to support biomarker discovery and personalized medicine research.

Financial terms of the agreement were not released.

The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.